NCT03322358

Brief Summary

A large body of medical research has shown that sleep deprivation adversely affects outcomes ranging from cognitive function to pain sensitivity and cardiovascular function. Much of this evidence comes from sleep labs in the developed world, where sleep can be carefully manipulated, and short-run physiological and cognitive outcomes precisely measured. In contrast, there is much less knowledge about how sleep deprivation affects the health of individuals in the developing world, coming from a lack of studies outside the lab and over longer periods. This project aims to fill this gap. The investigators will implement a randomized controlled trial (RCT) with 450 low-income adults in Chennai, India, providing the first objective measurement of sleep in a developing country. The investigators will also evaluate scalable interventions to improve the sleep of poor adults, such as providing home sleep-aid devices and a comfortable space for a 30-minute afternoon nap at the participants' work site. Finally, the study aims to assess the impact of improved sleep on health, with a primary focus on cardiovascular health and cognitive outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
452

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2017

Completed
11 days until next milestone

Study Start

First participant enrolled

October 23, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 26, 2017

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
3.7 years until next milestone

Results Posted

Study results publicly available

September 21, 2023

Completed
Last Updated

September 21, 2023

Status Verified

November 1, 2022

Enrollment Period

2.2 years

First QC Date

October 12, 2017

Results QC Date

December 15, 2021

Last Update Submit

November 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sleep Per 24 Hours

    Sleep is measured via actigraph. 24 hour sleep is the sum of night sleep and nap sleep.

    Actigraphs are worn consistently throughout the study. The sleep per 24 hour period outcome is then measured every day through study completion, which is 28 business days (as well as intervening holidays and Sundays) for each participant.

Secondary Outcomes (11)

  • Blood Pressure

    From date of entering the study through completion of the study after 28 business days, blood pressure is measured once every block of three business days. The date of measurement is randomized within each block between the first, second, and third day.

  • Depression

    Depression is measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant.

  • Number of Days of Illness in Past Week

    Illness is measured once in the baseline on the first day of the study and a second time in the endline, which takes place on the last day of the study, 28 business days after the first day in the study for the participant.

  • Inhibitory Control

    From date of entering the study through completion of the study after 28 business days, the inhibitory control is measured once every two business days (which of the two is randomly assigned).

  • Memory

    From date of entering the study through completion of the study after 28 business days, memory is measured once every two business days (which of the two is randomly assigned).

  • +6 more secondary outcomes

Study Arms (6)

Control

NO INTERVENTION

No changes to normal sleep habits.

Naps only

EXPERIMENTAL

After a baseline period, participants in this condition will be provided with the opportunity to nap in a quiet comfortable "nap cabin" in the study office for 30 minutes each afternoon on all work days.

Other: Naps

Home sleep aids only

EXPERIMENTAL

After a baseline period, participants in this condition will be provided with a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful.

Device: Home sleep aids

Home sleep aids + Sleep incentives

EXPERIMENTAL

After a baseline period, participants in this condition will be provided with a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful. In addition, they will be given a small payment for each additional minute of sleep over their mean nighttime sleep in the baseline period.

Device: Home sleep aidsOther: Sleep incentives

Naps + Home sleep aids

EXPERIMENTAL

After a baseline period, participants in this condition will be provided with: 1) the opportunity to nap in a quiet comfortable "nap cabin" in the study office for 30 minutes each afternoon on all work days, 2) a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful.

Other: NapsDevice: Home sleep aids

Naps + Home sleep aids + Sleep incentives

EXPERIMENTAL

After a baseline period, participants in this condition will be provided with: 1) the opportunity to nap in a quiet comfortable "nap cabin" in the study office for 30 minutes each afternoon on all work days, 2) a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish, and 3) a small payment for each additional minute of sleep over their mean nighttime sleep in the baseline period. The sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful.

Other: NapsDevice: Home sleep aidsOther: Sleep incentives

Interventions

NapsOTHER

After a baseline period, participants in this condition will be provided with the opportunity to nap in a quiet comfortable "nap cabin" in the study office for 30 minutes each afternoon on all work days.

Naps + Home sleep aidsNaps + Home sleep aids + Sleep incentivesNaps only

After a baseline period, participants in this condition will be provided with a set of home sleep aids (e.g. earplugs, eyeshades, a basic mattress, sheets, and pillow, etc) to take home with them if they wish. These sleep aids and their proper use are described to the participants and they are encouraged to use them if they find them helpful.

Home sleep aids + Sleep incentivesHome sleep aids onlyNaps + Home sleep aidsNaps + Home sleep aids + Sleep incentives

After a baseline period, participants in this condition will be provided with a small payment for each additional minute of sleep over their mean nighttime sleep in the baseline period.

Home sleep aids + Sleep incentivesNaps + Home sleep aids + Sleep incentives

Eligibility Criteria

Age25 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Unemployed and underemployed adult men and women of working age (see previous age limit) who have worked less than 5 days per week over the last month and earned less than Rs. 700 per day over that same period.
  • Participants must live in Government board house or in a house with some kind of roof that protect the sleep aids from rain, such as a concrete or a metal or a Tarpaulin, ... roof.
  • Have limited experience with typing, and limited knowledge of English.
  • Participants need to speak Tamil, the local language, to be able to write numbers and to be able to commit easily to the office.

You may not qualify if:

  • Participants who cannot commit to come to the office for the duration of the whole study.
  • Participants who own more than three of the sleep aids that we provide in our sleep kit.
  • Participants who have previously participated in the sleep study.
  • Participants who have children younger than three years old.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Institute for Financial Management and Research

Chennai, Tamil Nadu, 600006, India

Location

J-PAL South Asia

Chennai, Tamil Nadu, 600006, India

Location

Related Publications (1)

  • Bessone P, Rao G, Schilbach F, Schofield H, Toma M. The Economic Consequences of Increasing Sleep Among the Urban Poor. Q J Econ. 2021 Apr 8;136(3):1887-1941. doi: 10.1093/qje/qjab013. eCollection 2021 Aug.

MeSH Terms

Conditions

Depression

Interventions

N-(4-aminophenethyl)spiroperidol

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Results Point of Contact

Title
Heather Schofield
Organization
University of Pennsylvania

Study Officials

  • Gautam Rao, PhD

    Harvard University

    PRINCIPAL INVESTIGATOR
  • Frank Schilbach, PhD

    Massachusetts Institute of Technology

    PRINCIPAL INVESTIGATOR
  • Margaret McConnell, PhD

    Harvard School of Public Health (HSPH)

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 12, 2017

First Posted

October 26, 2017

Study Start

October 23, 2017

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

September 21, 2023

Results First Posted

September 21, 2023

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will share

We will make the de-identified data available upon request after publication.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
After publication.

Available IPD Datasets

Individual Participant Data Set Access

Locations